Leptin Concentrations in the Polycystic Ovary Syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 6, 1997, Pages 1687-1691

  Mantzoros, Christos S ^a   Dunaif, Andrea ^b   Flier, Jeffrey S ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CHROMAN DERIVATIVE; INSULIN; LEPTIN; PROTEIN; THIAZOLE DERIVATIVE; TROGLITAZONE;

ADULT; ARTICLE; BLOOD; BODY MASS; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERINSULINISM; INSULIN RESISTANCE; OBESITY; OSMOLARITY; OVARY POLYCYSTIC DISEASE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BODY MASS INDEX; CHROMANS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LEPTIN; OBESITY; OSMOLAR CONCENTRATION; POLYCYSTIC OVARY SYNDROME; PROTEINS; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0031154336     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.6.1687     Document Type: Article

References (47)

1. Franks S. 1995 Polycystic ovary syndrome. N Engl J Med. 333:853-861.
2. Dunaif A. 1993Insulin resistance and ovarian dysfunction. In: Moller DE, ed. Insulin resistance, 1st ed. Chichester: Wiley and Sons; 301-325.
3. Mantzoros CS, Flier JS. 1995 Insulin resistance: the clinical spectrum. Adv Endcorinol Metab. 6:193-232.
4. Book CB, Dunaif A. 1996 Insulin resistance in the polycystic ovary syndrome. In: Chang RJ, ed. Polycystic ovary syndrome. Serono Symp USA. New York: Springer-Verlag; 117-125.
5. Dunaif A. 1995 Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med. 98:33S-39S.
6. Dunaif A, Xia J, Book CB, Schenker E, Tang Z. 1995 Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest. 96:801-810.
7. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse ob gene and its human homologue. Nature. 372:425-432.
8. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. 1995 Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:546-548.
9. Rink TJ. 1995 In search of a satiety factor. Nature. 372:406-407.
10. Spiegelman BM, Flier JS. 1996 A dipogenesis and obesity: rounding out the big picture. Cell. 87:377-389.
11. Caro JF, Sinha MK, Kolaczynski JW, Zhary PL, Considine RV. 1996 Leptin: the tale of an obesity gene. Diabetes. 45:1455-1462.
12. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1:1155-1161.
13. Frederich RC, Hamann A, Anderson S, Lollman B, Lowell BB, Flier JS. 1995 Leptin reflects body lipid content in mice: evidence for diet-induced leptin resistance. Nat Med. 1:1311-1314.
14. Considine R, Sinha M, Heiman M, et al. 1996 Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med. 334:292-295.
15. Frederich RC, Lollmann B, Hamann A, et al. 1995 Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest. 96:1658-1663.
16. Rohner-Jeanrenaud F, Jeanrenaud B. 1996 Obesity, leptin, and the brain. N Engl J Med. 334:324-325.
17. Chehab F, Lim M, Lu R. 1996 Correction of the sterility detect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 12:318.
18. Barash IA, Cheung CC, Weigle DS, et al. 1996 Leptin is a metabolic signal to the reproductive system. Endocrinology. 137:3144-3147.
19. Ahima R, Prabakaran D, Mantzoros C, et al. 1996 Role of leptin in the neuroendocrine responce to fasting. Nature. 382:250-252.
20. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS. Leptin accelerates the timing of puberty in normal female mice. J Clin Invest. In press.
21. Saladin R, De Vos P, Guerre-Millo M, et al. 1995 Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:527-529.
22. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. 1995 The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes. 44:1467-1470.
23. Vidal H, Auboeuf D, De Vos P, et al. 1996 The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest. 98:251-255.
24. Kolaczynski JW, Nyce MR, Considine RV, et al. 1996 Acute and chronic effect of insulin on leptin production in humans. Diabetes. 45:699-701.
25. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landl M. 1996 Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes. 45:695-698.
26. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. 1996 Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes. 45:822-824.
27. Brzechffa PR, Jakimiuk AJ, Agarwal SK, et al. 1996 Serum immunoreactive leptin concentrations in women with polycystic ovarian disease. J Clin Endocrinol Metab. 81:4166-4169.
28. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. 1996 The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:3299-3306.
29. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 41:1257-1266.
30. Modan M, Harris MI, Halkin H. 1989 Evaluation of WHO, and NDDG criteria for impaired glucose tolerance. Diabetes. 38:1603-1635.
31. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Khan BB. 1996 Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes. 45:1638-1643.
32. Mantzoros CS, Flier JS, Rogol AD. 1997 A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab. 82:1066-1070.
33. 269Pro mutation in the leptin receptor (Lepr). Diabetes 45:1141-1143.
34. Lee GH, Proenca R, Montez JM, et al. 1996 Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:632-635.
35. Chen H, Charlat O, Tartaglia LA, et al. 1996 Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 84:491-495.
36. Halaas JL, Gajiwala KS, Maffei M, et al. 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543-546.
37. Pelleymounter MA, Cullen MJ, Baker MB, et al. 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:540-543.
38. Weigle DS, Bukowski TR, Foster DC, et al. 1995 Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest. 96:2065-2070.
39. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. 1996 Leptin and fat regulation. Nature. 360:677.
40. Nolan JJ, Olefsky JM, Nyce MR, Considine RV, Caro JF. 1996 Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes. 45:1276-1278.
41. Hardie LJ, Rayner DV, Holmes S, Trayhurn P. 1996 Circulating leptin levels are modulated by fasting, cold exposure, and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA. Biochem Biophys Res Commun. 223:660-665.
42. Segal KR, Landt M, Klein S. 1996 Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 45:988-991.
43. Sinha MK, Ohanessian JP, Heinman ML, et al. 1996 Nocturnal rise of leptin in lean, obese, and non-insulin dependent diabetes mellitus subjects. J Clin Invest. 97:1344-1347.
44. Lehman JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kliever SA. 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator activator receptor gamma. J Biol Chem. 270:12953-12956.
45. Kallen CB, Lazar MA. 1996 Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA. 93:5793-5796.
46. De Vos P, Lefebre AM, Miller SG, et al. 1996 Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator activator receptor gamma. J Clin Invest. 98:1004-1009.
47. Zhang B, Graziano MP, Doebber TW, et al. 1996 Down-regulation of the expression of the obese gene by an antiadiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem. 271:9455-9459.